CRO · Private company
IQVIA Biotech
Track this companyFree. Adds IQVIA Biotech to your Dealase workspace and tells you when its record changes.
Clinical trials151 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials15
- To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring HemodialysisPHASE3 · ACTIVE_NOT_RECRUITING · started Sep 7, 2023ClinicalTrials.gov NCT05908084 · fetched Nov 12, 2026
- ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial DefectsPHASE2 · TERMINATED · started Apr 27, 2022ClinicalTrials.gov NCT05066698 · fetched Nov 12, 2026
- A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRDPHASE2 · COMPLETED · started Feb 1, 2022ClinicalTrials.gov NCT05414422 · fetched Nov 12, 2026
- Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian CancerPHASE1 · TERMINATED · started Jun 11, 2021ClinicalTrials.gov NCT04907968 · fetched Nov 12, 2026
- Safety and Tolerability Study of IV ST266 in COVID-19 SubjectsPHASE1 · COMPLETED · started May 30, 2021ClinicalTrials.gov NCT04720378 · fetched Nov 12, 2026
- First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2bPHASE1 · TERMINATED · started May 11, 2020ClinicalTrials.gov NCT04396340 · fetched Nov 12, 2026
- Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult ParticipantsPHASE1 · TERMINATED · started Dec 12, 2019ClinicalTrials.gov NCT04167137 · fetched Nov 12, 2026
- A Pilot Study of BXCL701 in Patients With Pancreatic CancerEARLY_PHASE1 · WITHDRAWN · started Oct 15, 2019ClinicalTrials.gov NCT04123574 · fetched Nov 12, 2026
- Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303PHASE3 · COMPLETED · started Sep 23, 2019ClinicalTrials.gov NCT04072835 · fetched Nov 12, 2026
- Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)PHASE3 · COMPLETED · started Aug 13, 2019ClinicalTrials.gov NCT04053387 · fetched Nov 12, 2026
- Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)PHASE3 · COMPLETED · started Jun 6, 2019ClinicalTrials.gov NCT03983980 · fetched Nov 12, 2026
- Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)PHASE3 · COMPLETED · started May 21, 2019ClinicalTrials.gov NCT03956355 · fetched Nov 12, 2026
- DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2PHASE1_PHASE2 · COMPLETED · started Sep 18, 2018ClinicalTrials.gov NCT03466320 · fetched Nov 12, 2026
- Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT).PHASE3 · TERMINATED · started Jun 18, 2018ClinicalTrials.gov NCT03464019 · fetched Nov 12, 2026
- Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular MelanomaPHASE3 · COMPLETED · started Feb 1, 2016ClinicalTrials.gov NCT02678572 · fetched Nov 12, 2026